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rence. She underwent radiosurgery with 13 Gy of marginal 
dose and she was subjected to third GKS with 15 Gy of margin-
al dose on local recurrent lesion after 2 years from second GKS 
(Fig. 2B, C). At 58 months from the initial GKS, which is also 
72 months from the first operation the patient experienced se-
vere headache with vomiting and a huge new lesion was found 
in the area of the previous radiosurgery (Fig. 3). She underwent 
the second craniotomy and tumor removal. On this occasion, 
the pathological finding was consistent with glioblastoma (Fig. 
4). She was treated with concomitant chemo-radiotherapy (to-
tal dose of irradiation 6000 cGy over 30 fractions and oral te-
INTRODUCTION
 
Cranial irradiation has been widely used as a therapeutic meth-
od treating a wide variety of lesions, particularly neoplasms. 
Though radiation therapy of central nervous system is usually 
well-tolerated, it does occasionally cause clinically significant 
long-term toxicity such as late delayed radiation necrosis and ir-
radiation-related arteriopathy with stroke14). Among other com-
plications induction of neoplasm is a rare but well-documented 
serious sequela of therapeutic irradiation. Radiosurgery is not 
free from this problem although there are only a few reported 
cases14). We report a case of glioblastoma which was developed 
after gamma knife radiosurgery (GKS) for meningioma.
CASE REPORT
A 47-year-old woman presented with headache, anosmia, and 
visual dimness. Large extra-axial mass originating from olfacto-
ry groove and both frontal base was found on MRI (Fig. 1). She 
underwent gross total tumor removal, and the pathological di-
agnosis of meningotheliomatous meningioma was confirmed. 
Approximately 1 year after surgery, the follow-up MRI scan re-
vealed tumor recurrence. She underwent GKS with 16 Gy of 
marginal dose at 50% isodose line (Fig. 2A). Three years after 
initial radiosurgery, the subsequent MRI scan revealed tumor 
progression at a location different from the previous recur-
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Fig. 1. T1-weighted contrast enhanced magnetic resonance image 
showing well enhanced frontal meningioma upon the olfactory groove.99
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interval between radiotherapy and the detection of the second 
tumor (usually several years); 3) a histological difference exists 
between the primary and subsequent tumor; and 4) no known 
genetic or predisposing conditions to secondary malignancy 
are observed. In other series, the criterion of latent period in ra-
diation induced tumor was set to 5 years5,6,13). However, the “5 
year” period is not accepted as an absolute standard due to in-
sufficient biologic evidence. Therefore, the present case could 
be considered as radiation induced tumor. In this way, the pres-
ent case fits the all criteria and deserves to be diagnosed as radi-
ation-induced malignancy.
 The mechanism of radiation- induced neoplasms is multifac-
eted and not well understood. However, radiation is now well 
recognized to be a trigger, not only a treatment, for cancer. When 
the cells are irradiated, the probability of malignancy increases 
with dose, most likely with no threshold. That is, no dose is too 
small to be effective. This view is based on experimental data 
showing that even a single photon can cause a base change lead-
ing to mutations that eventually can cause malignancy. In con-
trast, the severity of malignancy is not dose related. That is, a 
cancer induced by a small dose of radiation is not less harmful 
than a cancer induced by a large dose. Furthermore, the abso-
lute value of radiation dose in stereotactic radiosurgery is low. 
But, in the concept of biological equivalent dose, it is not a low-
dose treatment, thus it could cause radiation induced tumor. 
mozolomide 75 mg/m2/day during the radiotherapy period) fol-
lowed by adjuvant chemotherapy with oral temozolomide. First 
cycle was consisted of 150 mg/m2/day temozolomide for 5 days, 
and subsequent 5 cycles were maintained with 200 mg/m2/day 
for 5 days with 4 weeks interval between each cycle. The tumor 
progression was significant at 11 months from the diagnosis of 
glioblastoma with neurological deterioration. Ventriculoperito-
neal shunt was done for progressive hydrocephalus. Currently, 
she is alive at the time of this writing (15 months after diagnosis 
of glioblastoma) with only supportive management.
DISCUSSION
There is now increasing concern regarding the potential for 
radiation-induced neoplasm, because of the intensive use of ra-
diotherapy under a wide range of doses and treatment condi-
tions resulting in a longer survival of brain tumor patients2,14,24). 
Despite the reported documents about the safety of radiosur-
gery, additional reports of glioma induction after radiosurgery 
may temper its use in the treatment of benign lesions, such as 
meningiomas, particularly in younger patients10,12). The follow-
ing criteria for radiation-induced neoplasms have been previ-
ously described7,11) : 1) a second tumor occurs within the field 
of irradiation used to treat the primary disease; 2) the tumor is 
not present prior to irradiation, and there has been a reasonable 
A B C
Fig. 2. First Gamma Knife Surgery planning for meningioma which maximum radiating doses were 30 Gy on July 2004 (A) and 25 Gy on May 2007 
(B) and 28 Gy on May 2009 (C).
Fig. 3. T1-weighted contrast enhanced magnetic resonance image 
demonstrating a mass with peripheral enhancement and central necro-
sis involving both frontal lobes with extension into the corpus callosum 
after 58 months from diagnosis of GM.
Fig. 4. Photomicrographs of the lesion demonstrate an infiltrating glial 
neoplasm comprised of highly atypical cells with pleomorphic angular 
nuclei and modest eosinophilic cytoplasm consistent with astrocytic lin-
eage. Numerous mitoses and tumoral necrosis are present. This presen-
tation is compatible with a glioblastoma.100
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lead to transforming mutations. The efficiency of tumor induc-
tion varies inversely with repair capacity, which in turn depends 
on the integrity of cell cycle check-points3,9). The general form 
of the dose-response curve for radiation associated second tu-
mors is not clear, but several experiments on small animals sug-
gest that the incidence increases with dose up to a maximum 
usually occurring between 3 and 10 Gy, followed by a subse-
quent monotonic decrease3). There are also studies reporting 
that the highest incidence of radiation associated second tu-
mors occurs at field peripheries, where the dose is less than at 
the field center9). Most of the reported cases of radiation-associ-
ated tumor were related to conventional radiotherapy. However, 
malignant tumors after GKS of benign tumors have rarely been 
discussed. There were small number of malignant neoplasms 
after treatment of vestibular schwannoma, meningioma or arte-
riorvenous malformation (Table 1). Considering that carcino-
genetic potential is not necessarily dose-dependent and sub-
lethal damage and repair errors are required for development of 
secondary tumors, single session radiosurgery may be relatively 
safer than fractionated radiotherapy with repeated chance of 
sublethal damage. However, it seems that radiation-induced 
malignancy can occur within very low-dose peripheral regions 
as well as the full-dose regions. Because the number of the pa-
tients who underwent radiosurgery and long-term follow up is 
much smaller than that treated with fractionated radiotherapy, 
relative safety of radiosurgery needs to be proven by further ac-
cumulation of clinical data. We draw a conclusion that the num-
ber of GKS performed, is not important. As cumulative level of 
radiation increases by the repeated GKS, so does the oncogenic 
opportunity. In the present study, the cumulative radiation dose 
of three repeated GKS is higher than that of conventional radio-
therapy, leading to oncogenic change. In our series, clinical out-
come was not different and as poor as primary glioblastoma 
treated with standard treatment of surgery, radiotherapy and 
chemotherapy. Although malignancy after radiosurgery is very 
rare, its impact is not acceptable considering the benign nature 
of the primary disease. No one knows for sure that how much 
The lower incidence of radiation induced tumor in radiosur-
gery, could be explained by relatively smaller volume of normal 
tissue exposed to radiation compared to conventional radia-
tion. Brada et al.4) reported the risk of second brain tumor for-
mation in 334 patients treated for pituitary tumors with surgery 
and fractionated small-field irradiation (median dose, 45 Gy). 
With a cumulative follow-up period of 3760 years, five patients 
developed second tumors (two astrocytomas, two meningio-
mas, and one meningeal sarcoma). The latency period is similar 
to what has been seen with fractionated therapy in the several 
years period after radiosurgery, and malignant tumors occur 
earlier than their benign tumor counterparts. The cumulative 
risk of developing second brain tumors was 1.3% at 10 years 
and 1.9% at 20 years. The relative risk of a second brain tumor 
was 9.38 compared with the normal population4).
 Concerning the risk of developing a secondary neoplasm, sev-
eral factors such as patient age, tissue vulnerability, radiation type 
and dose, underlying disease, and additional chemotherapy may 
all play an important role2,4,17,24,25). The relative risk of a secondary 
tumor following cranial irradiation in children has been estimat-
ed to be from 2.6 to 38.8 compared with the risk in the standard 
population8,15,22) while in the adult population it was estimated to 
be from 9.38 to 164,24). In some cases, younger patients have been 
reported more vulnerable for second tumor development. Sa-
detzki et al.16) described 253 patients who developed meningio-
mas after radiation for tinea capitis. The mean time from expo-
sure to meningioma diagnosis was 36 years (range, 12-49 year). 
The authors found a higher incidence of multiple lesions, a 
younger age at diagnosis, and a higher percentage of calvarial le-
sions than in control patients who developed meningiomas with-
out previous exposure to ionizing radiation16).
The toxicity of therapeutic doses of radiation is primarily acute. 
However, the carcinogenic effects are not restricted to those tis-
sues manifesting clinical toxicity. In fact, the opposite may be 
more accurate, because high dose of radiation may sterilize the 
carcinogenic potential of a tissue by killing cells. Only in those 
cells that are not killed deoxyribonucleic acid repair errors may 
Table 1. Summary of the radiosurgery induced malignant brain tumor described in literature (including our case)
Series Sex/Age (yr) Date of treatment Initial diagnosis Dose (Gy) Technique Interval (yr) Second tumor
Shamisa et al.
20) F/57 1992 VS 11 GKS     7.5 GBM
Kaido et al.
10)   M/14 1992 AVM 20 GKS 7 GBM
Yu et al.
27) F/57 1992 MNG 20 GKS 7 GBM
Shin et al.
21) F/26 1995 VS 17 GKS 6 MS
Thomsen et al.
23) F/20 2000 VS 15 GKS 6 Meningiosarcoma
Bari et al.
1) F/30 2002 VS 15 GKS 4 MPNST
Salvati et al.
18) F/66 2003 Cavernoma 10 GKS 13 GBM
Sanno et al.
19) F/53 2004 MNG 30 GKS 4 Malignant osteosarcoma
Yang et al.
26) F/73 2007 VS     12.5 GKS 6 Sarcoma
Present study F/47 2004 MNG 44 GKS 5 GBM
Date of treatment : at time of the first radiosurgery, Dose : marginal doses or cumulative doses, Interval : time from radiosurgery to second tumor diagnosis, VS : vestib-
ular schwannoma, AVM : ateriovenous malformation, MNG : meningioma, GBM : glioblastoma multiforme, MS : malignant schwannoma, MPNST : malignant peripheral 
nerve sheath tumor, GKS : gamma knife radiosurgery101
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12. McIver JI, Pollock BE : Radiation-induced tumor after stereotactic ra-
diosurgery and whole brain radiotherapy : case report and literature re-
view. J Neurooncol 66 : 301-305, 2004
13. Muracciole X, Régis J : Radiosurgery and carcinogenesis risk. Prog 
Neurol Surg 21 : 207-213, 2008
14. Nishio S, Morioka T, Fukui M : Radiation injury of the brain. Crit Rev 
Neurosurg 7 : 408-415, 1997
15. Ron E, Modan B, Boice JD Jr, Alfandary E, Stovall M, Chetrit A, et al. : 
Tumors of the brain and nervous system after radiotherapy in child-
hood. N Engl J Med 319 : 1033-1039, 1988
16. Sadetzki S, Flint-Richter P, Ben-Tal T, Nass D : Radiation-induced me-
ningioma : a descriptive study of 253 cases. J Neurosurg 97 : 1078-1082, 
2002
17. Salvati M, Cervoni L, Puzzilli F, Bristot R, Delfini R, Gagliardi FM : 
High-dose radiation-induced meningiomas. Surg Neurol 47 : 435-441; 
discussion 441-442, 1997
18. Salvati M, Frati A, Russo N, Caroli E, Polli FM, Minniti G, et al. : Radia-
tion-induced gliomas : report of 10 cases and review of the literature. 
Surg Neurol 60 : 60-67; discussion 67, 2003
19. Sanno N, Hayashi S, Shimura T, Maeda S, Teramoto A : Intracranial os-
teosarcoma after radiosurgery--case report. Neurol Med Chir (Tokyo) 
44 : 29-32, 2004
20. Shamisa A, Bance M, Nag S, Tator C, Wong S, Norén G, et al. : Glioblas-
toma multiforme occurring in a patient treated with gamma knife sur-
gery. Case report and review of the literature. J Neurosurg 94 : 816-821, 
2001
21. Shin M, Ueki K, Kurita H, Kirino T : Malignant transformation of a ves-
tibular schwannoma after gamma knife radiosurgery. Lancet 360 : 309-
310, 2002
22. Soffer D, Pittaluga S, Feiner M, Beller AJ : Intracranial meningiomas 
following low-dose irradiation to the head. J Neurosurg 59 : 1048-1053, 
1983
23. Thomsen J, Mirz F, Wetke R, Astrup J, Bojsen-Møller M, Nielsen E : In-
tracranial sarcoma in a patient with neurofibromatosis type 2 treated 
with gamma knife radiosurgery for vestibular schwannoma. Am J Otol 
21 : 364-370, 2000
24. Tsang RW, Laperriere NJ, Simpson WJ, Brierley J, Panzarella T, Smyth 
HS : Glioma arising after radiation therapy for pituitary adenoma. A re-
port of four patients and estimation of risk. Cancer 72 : 2227-2233, 1993
25. Tucker MA, D’Angio GJ, Boice JD Jr, Strong LC, Li FP, Stovall M, et al. : 
Bone sarcomas linked to radiotherapy and chemotherapy in children. N 
Engl J Med 317 : 588-593, 1987
26. Yang T, Rockhill J, Born DE, Sekhar LN : A case of high-grade undiffer-
entiated sarcoma after surgical resection and stereotactic radiosurgery 
of a vestibular schwannoma. Skull Base 20 : 179-183, 2010
27. Yu JS, Yong WH, Wilson D, Black KL : Glioblastoma induction after ra-
diosurgery for meningioma. Lancet 356 : 1576-1577, 2000
dose of the radiation causes oncogenic transformation. There-
fore, the possibility of this fatal complication should be balanced 
always in case of radiosurgery. 
CONCLUSION
 
We experienced a case of radiosurgery-associated glioblasto-
ma that developed after GKS for meningioma. Although the 
risk of radiosurgery-associated tumor is very low, application of 
radiosurgery for benign tumors should be very cautious because 
its occurrence is fatal to the patients.
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